Dipharma
About Dipharma
Certifications
Categories
-
IT
-
2015On CPHI since
-
3Certificates
-
250 - 499Employees
Company types
Primary activities
Meet us at
CPHI Americas 2025
Pennsylvania Convention Center, Philadelphia
20 May 2025 - 22 May 2025
CPHI Frankfurt 2025
Messe, Frankfurt
28 Oct 2025 - 30 Oct 2025
Products from Dipharma (41)
-
Product Bendroflumethiazide
Dipharma manufactures wide range of active pharmaceutical ingredients which includes Bendroflumethiazide. It belongs to commercial products category. Therapeutic category: Diuretic. Contact us for more information. -
Product Aminocaproic Acid
Dipharma manufactures wide range of Active Pharmaceutical Ingredients which includes Aminocaproic Acid. It belongs to new products category. Therapeutic category: Treatment of bleeding disorders. Contact us for more information.
-
Product Amitriptyline Hydrochloride
Dipharma manufactures wide range of active pharmaceutical ingredients which includes Amitriptyline Hydrochloride. It belongs to commercial products category. Therapeutic category: Antidepressant. Contact us for more information. -
Product Benserazide Hydrochloride
Dipharma manufactures wide range of active pharmaceutical ingredients which includes Benserazide Hydrochloride. It belongs to new products category. Therapeutic category: Antiparkinson. Contact us for more information. -
Product Biperiden Hydrochloride
Dipharma manufactures wide range of active pharmaceutical ingredients which includes Biperiden Hydrochloride. It belongs to new products category. Therapeutic category: Antiparkinson. Contact us for more information. -
Product Bupropion Hydrochloride
Dipharma manufactures wide range of active pharmaceutical ingredients which includes Bupropion Hydrochloride. It belongs to commercial products category. Therapeutic category: Antidepressant. Contact us for more information. -
Product Chenodeoxycholic Acid*
Dipharma manufactures wide range of active pharmaceutical ingredients which includes Chenodeoxycholic Acid*. It belongs to new products category. Therapeutic category: Bile Stone Therapy, Plain antitussives. Contact us for more information.
* only for specific markets. See our web site -
Product Crisaborole
Dipharma manufactures wide range of active pharmaceutical ingredients which includes Crisaborole. It belongs to new products category. Therapeutic category: Treatment of atopic dermatitis and psoriasis. Contact us for more information. -
Product Cyclobenzaprine Hydrochloride
Dipharma manufactures wide range of active pharmaceutical ingredients which includes Cyclobenzaprine Hydrochloride. It belongs to commercial products category. Therapeutic category: Muscle Relaxant. Contact us for more information. -
Product Dapsone
Dipharma manufactures wide range of active pharmaceutical ingredients which includes Dapsone. It belongs to new products category. Therapeutic category: Antibacterial. Contact us for more information. -
Product Dexlansoprazole Anhydrous Crystalline
Dipharma manufactures wide range of active pharmaceutical ingredients which includes Dexlansoprazole Anhydrous Crystalline. It belongs to new products category. Therapeutic category: Antiulcerative. Contact us for more information. -
Product Diclofenac Epolamine
Dipharma manufactures wide range of active pharmaceutical ingredients which includes Diclofenac Epolamine. It belongs to new products category. Therapeutic category: Anti-inflammatory. Contact us for more information.
Dipharma Resources (4)
-
News Successful FDA Inspection at Dipharma Facility in Kalamazoo, MI, USA
Dipharma Inc. has been inspected by the US FDA and has received the EIR, satisfactorily closing the inspection process. The Company expands its range of CGMP services to include small-scale commercial APIs. -
Video Development and Manufacturing of New APIs: Leveraging Experience, Technological Innovation, and Present Vision to Future Success.
In today’s globalized economy, international integration plays a crucial role in the development of new molecules. This integration encompasses various aspects, including the transfer of production activities and the utilization of past experiences. Risk and Innovation: The development of APIs (active pharmaceutical ingredients) utilizes innovative process techniques and potentially hazardous chemical reactions. Leveraging past experiences is essential to mitigate risks and optimize production. Solid-State Development: A deep understanding of solid-state properties is critical for API manufacturers. Solid-state characterization ensures product stability, bioavailability, and manufacturability. -
News Dipharma expands its Italian R&D Center to increase its analytical services
The Company strengthens its analytical R&D capabilities, to better support its customers operating in the CDMO and Generics market.
-
Video The Dipharma Group - Experience you can trust
The Dipharma Group is a global Contract Development and Manufacturing Organization (CDMO) and a leading manufacturer of Active Pharmaceutical Ingredients (APIs), New Chemical Entities (NCE), and advanced Intermediates for Generic and Contract Manufacturing markets, offering APIs with DMFs registered worldwide.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance